DK1218037T3 - In vivo-assay til testning af den fænotypiske stabilitet - Google Patents
In vivo-assay til testning af den fænotypiske stabilitetInfo
- Publication number
- DK1218037T3 DK1218037T3 DK00967443T DK00967443T DK1218037T3 DK 1218037 T3 DK1218037 T3 DK 1218037T3 DK 00967443 T DK00967443 T DK 00967443T DK 00967443 T DK00967443 T DK 00967443T DK 1218037 T3 DK1218037 T3 DK 1218037T3
- Authority
- DK
- Denmark
- Prior art keywords
- chondrocytes
- vivo assay
- outcome
- phenotypic stability
- stability
- Prior art date
Links
- 238000005462 in vivo assay Methods 0.000 title abstract 2
- 210000001612 chondrocyte Anatomy 0.000 abstract 6
- 238000000018 DNA microarray Methods 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 241000699670 Mus sp. Species 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 239000006285 cell suspension Substances 0.000 abstract 1
- 230000002950 deficient Effects 0.000 abstract 1
- 230000012010 growth Effects 0.000 abstract 1
- 238000010255 intramuscular injection Methods 0.000 abstract 1
- 239000007927 intramuscular injection Substances 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000003908 quality control method Methods 0.000 abstract 1
- 238000010254 subcutaneous injection Methods 0.000 abstract 1
- 239000007929 subcutaneous injection Substances 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 230000017423 tissue regeneration Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
- A61K49/0006—Skin tests, e.g. intradermal testing, test strips, delayed hypersensitivity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
- A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pathology (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Zoology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Materials For Medical Uses (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99203273 | 1999-10-06 | ||
EP00967443A EP1218037B1 (en) | 1999-10-06 | 2000-10-06 | In vivo assay for testing the phenotypic stability |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1218037T3 true DK1218037T3 (da) | 2005-04-25 |
Family
ID=8240723
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00967443T DK1218037T3 (da) | 1999-10-06 | 2000-10-06 | In vivo-assay til testning af den fænotypiske stabilitet |
Country Status (12)
Country | Link |
---|---|
US (2) | US7479367B1 (pt) |
EP (2) | EP1498146A3 (pt) |
AT (1) | ATE285797T1 (pt) |
AU (1) | AU7764200A (pt) |
CA (1) | CA2397610C (pt) |
CY (1) | CY2010007I1 (pt) |
DE (3) | DE20023659U1 (pt) |
DK (1) | DK1218037T3 (pt) |
ES (2) | ES2488240T1 (pt) |
LU (1) | LU91672I2 (pt) |
PT (1) | PT1218037E (pt) |
WO (1) | WO2001024833A2 (pt) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1218037E (pt) * | 1999-10-06 | 2005-05-31 | Tigenix Nv | Ensaios in vitro e marcadores moleculares para testar a estabilidade fenotipica de populacoes de celulas, e populacoes de celulas seleccionadas para transplantacao autologa |
US7482114B2 (en) | 1999-10-06 | 2009-01-27 | Tigenix N.V. | In vivo assay and molecular markers for testing the phenotypic stability of cell populations, and selected cell populations for autologous transplantation |
AU2001266915A1 (en) | 2000-06-14 | 2001-12-24 | Case Western Reserve University | Probes for chondrogenesis |
WO2004013606A2 (en) * | 2002-08-02 | 2004-02-12 | Stratatech Corporation | Species specific dna detection |
NZ589814A (en) | 2006-03-20 | 2012-03-30 | Tigenix Nv | Methods to maintain, improve and restore the cartilage phenotype of chondrocytes |
US20100068715A1 (en) * | 2006-11-24 | 2010-03-18 | Tigenix N.V. | Marker genes for use in the identification of chondrocyte phenotypic stability and in the screening of factors influencing cartilage production |
CN101215565B (zh) * | 2008-01-11 | 2011-04-27 | 华中农业大学 | 一种作为猪标记辅助选择的与免疫性状相关的分子标记的克隆及应用 |
GB0902793D0 (en) | 2009-02-20 | 2009-04-08 | Univ Gent | GDF15 as molecular tool to monitor and enhance phenotypic stability of articular chondrocytes |
EP3872168A1 (en) * | 2020-02-28 | 2021-09-01 | Cline Scientific AB | Chondrocyte differentiation |
KR20230052963A (ko) | 2020-08-21 | 2023-04-20 | 젠자임 코포레이션 | Fgfr3 항체 및 사용 방법 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5837258A (en) * | 1991-08-30 | 1998-11-17 | University Of South Florida | Induction of tissue, bone or cartilage formation using connective tissue growth factor |
US5723331A (en) | 1994-05-05 | 1998-03-03 | Genzyme Corporation | Methods and compositions for the repair of articular cartilage defects in mammals |
US5902785A (en) * | 1995-06-06 | 1999-05-11 | Genetics Institute, Inc. | Cartilage induction by bone morphogenetic proteins |
JPH11507828A (ja) | 1995-06-12 | 1999-07-13 | イエーダ リサーチ アンド ディベロップメント カンパニー,リミテッド | Fgfr3に対して特異的なリガンドとしてのfgf9 |
AU742342B2 (en) | 1997-05-21 | 2001-12-20 | Clontech Laboratories, Inc. | Nucleic acid arrays |
WO1998059035A2 (en) | 1997-06-25 | 1998-12-30 | The Goverment Of The United States Of America, Represented By The Secretary, Dept. Of Health And Human Services, National Institutes Of Health | Serum-free cell growth medium |
DK1282690T3 (da) * | 1999-10-06 | 2005-02-28 | Tigenix Nv | Isolation af precursorceller og anvendelse deraf til vævsreparation |
PT1218037E (pt) * | 1999-10-06 | 2005-05-31 | Tigenix Nv | Ensaios in vitro e marcadores moleculares para testar a estabilidade fenotipica de populacoes de celulas, e populacoes de celulas seleccionadas para transplantacao autologa |
US7482114B2 (en) | 1999-10-06 | 2009-01-27 | Tigenix N.V. | In vivo assay and molecular markers for testing the phenotypic stability of cell populations, and selected cell populations for autologous transplantation |
-
2000
- 2000-10-06 PT PT00967443T patent/PT1218037E/pt unknown
- 2000-10-06 DK DK00967443T patent/DK1218037T3/da active
- 2000-10-06 AU AU77642/00A patent/AU7764200A/en not_active Abandoned
- 2000-10-06 DE DE20023659U patent/DE20023659U1/de not_active Expired - Lifetime
- 2000-10-06 DE DE122010000021C patent/DE122010000021I1/de active Pending
- 2000-10-06 ES ES04077642.9T patent/ES2488240T1/es active Pending
- 2000-10-06 EP EP20040077642 patent/EP1498146A3/en not_active Withdrawn
- 2000-10-06 DE DE60017159T patent/DE60017159T2/de not_active Expired - Lifetime
- 2000-10-06 CA CA2397610A patent/CA2397610C/en not_active Expired - Lifetime
- 2000-10-06 US US10/089,932 patent/US7479367B1/en not_active Expired - Fee Related
- 2000-10-06 AT AT00967443T patent/ATE285797T1/de active
- 2000-10-06 WO PCT/BE2000/000118 patent/WO2001024833A2/en active IP Right Grant
- 2000-10-06 ES ES00967443T patent/ES2234673T3/es not_active Expired - Lifetime
- 2000-10-06 EP EP00967443A patent/EP1218037B1/en not_active Expired - Lifetime
-
2008
- 2008-11-25 US US12/323,185 patent/US9089598B2/en not_active Expired - Fee Related
-
2010
- 2010-03-31 CY CY2010007C patent/CY2010007I1/el unknown
- 2010-04-02 LU LU91672C patent/LU91672I2/fr unknown
Also Published As
Publication number | Publication date |
---|---|
EP1498146A2 (en) | 2005-01-19 |
EP1218037B1 (en) | 2004-12-29 |
EP1218037A2 (en) | 2002-07-03 |
CA2397610A1 (en) | 2001-04-12 |
CY2010007I2 (el) | 2010-07-28 |
AU7764200A (en) | 2001-05-10 |
CY2010007I1 (el) | 2010-07-28 |
DE20023659U1 (de) | 2005-07-07 |
PT1218037E (pt) | 2005-05-31 |
US7479367B1 (en) | 2009-01-20 |
DE122010000021I1 (de) | 2012-09-06 |
CA2397610C (en) | 2012-07-03 |
ES2234673T3 (es) | 2005-07-01 |
US9089598B2 (en) | 2015-07-28 |
LU91672I2 (fr) | 2010-06-02 |
WO2001024833A2 (en) | 2001-04-12 |
DE60017159T2 (de) | 2006-05-04 |
ATE285797T1 (de) | 2005-01-15 |
EP1498146A3 (en) | 2007-01-24 |
DE60017159D1 (de) | 2005-02-03 |
ES2488240T1 (es) | 2014-08-26 |
US20090162328A1 (en) | 2009-06-25 |
WO2001024833A3 (en) | 2001-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LU91672I2 (fr) | ChondroCelect | |
Yamasaki et al. | Meniscal regeneration using tissue engineering with a scaffold derived from a rat meniscus and mesenchymal stromal cells derived from rat bone marrow | |
SE9303977D0 (sv) | Verfahren zur herstellung von implantatkeramikmaterial, insbesonders von hydroxylapatit aufweisenden implantatkeramikmaterial | |
ATE213590T1 (de) | Fgf9 als spezifischer ligand für fgfr3 | |
DE69028678D1 (de) | Maytansinoid enthaltende cytotoxische Mittel und ihre therapeutische Anwendung | |
YU12201A (sh) | Metodi, instrumenti i materijali za transplantaciju ćelija hondrocita | |
CY1109742T1 (el) | Μεθοδοι και συνθεσεις για επουλωση και αποκατασταση αρθρικου χονδρου | |
BR0214217A (pt) | Aumento de função de órgão | |
DE69934179D1 (de) | Zusammensetzung enthaltend, ein Antigen, ein TH-1 induzierendes Adjuvans und eine im Wasser schwer lösliche Aminosäure, zur Verwendung in der Immunisierung | |
DE60113570D1 (de) | Spritzgusspolymer | |
ATE429450T1 (de) | Chimärische dr4 antikörper und ihre verwendung | |
ATE203021T1 (de) | Verwendung von lactamverbindungen als pharmazeutische wirkstoffe | |
DK87190A (da) | Fremgangsmaade til at regulere plantevaekst under anvendelse af svovlholdige organiske syrer | |
DK2359854T3 (da) | Farmaceutiske sammensætninger og fremgangsmåder egnet til modulering af angiogenese | |
ID30073A (id) | Metode untuk menyambung, menandai dan memodifikasi secara struktural monofilamen-monofilamen | |
DE60034672D1 (de) | Reporterverbindungen und verfahren zur bestimmung des lipidisierungsstatus einer zelle | |
DE59507162D1 (de) | Verfahren zur Befestigung von Hängen | |
ES2151895T3 (es) | Procedimiento para la obtencion de cultivos celulares con alto contenido en citoquinas endogenas. | |
ATE481641T1 (de) | Verfahren zur fixierung eines proteins auf einem pyrrolpolymerisat, und dessen verwendung zur herstellung eines sensors | |
ATE455565T1 (de) | Verwendung eines biologischen materials mit dreidimensionalen gerüsten aus hyaluronsäure- derivaten | |
EP1188821A4 (en) | CARRIER FOR ANIMAL CELL CULTURE INCLUDING AN ORGAN TISSUE DISC AND ANIMAL CELL CULTURE METHOD AND TRANSPLANTATION METHOD USING SUCH A CARRIER | |
ATE172028T1 (de) | Zytodiagnostisches verfahren unter verwendung von alstonin als selektivem marker und diesen marker enthaltender diagnostischer kit | |
ATE248218T1 (de) | Humane hypertrophe chrondrozyten zelllinien | |
KR970701349A (ko) | 치주 및 페리-임플런트 질환 활성의 마커로서의 피리디놀린 가교체 | |
DE60022487D1 (de) | In vivo färbemittel und verwendungsmethoden zur identifizierung von dysplastischem gewebe |